Search
for
Sort by
Research 271–300 of 1000+
- Cutaneous manifestations of COVID-19 and vaccines for its prevention: a review of the existing literature
- Skin Diseases (Noncancerous)
- Table of Contents
- Acne and acneiform eruptions
- Demodicosis and rosacea: Epidemiology and significance in daily dermatologic practice
- Cutaneous reactions to chemotherapeutic drugs and targeted therapy for cancer
- What causes hidradenitis suppurativa ?—15 years after
- Dermatologic Manifestations of Human Immunodeficiency Virus Infection
- Oral Retinoids in Dermatology
- Skin Conditions in Figure Skaters, Ice-Hockey Players and Speed Skaters
- The Skin in Pregnancy
- A Practical Approach to the Diagnosis and Management of Hair Loss in Children and Adolescents
- Madarosis
- Clinical management of cutaneous adverse events in patients on targeted anticancer therapies and immunotherapies: a national consensus statement by the Spanish Academy of Dermatology and Venereology and the Spanish Society of Medical Oncology
- Skin disease in pregnancy
- Contraception and the dermatologist
- Systemic causes of hair loss
- Cutaneous adverse reactions linked to targeted anticancer therapies bortezomib and lenalidomide for multiple myeloma: new drugs, old side effects
- Niosomes as Carrier in Dermal Drug Delivery
- Improving Posttraumatic Facial Scars
- Cardiodermatology: the heart of the connection between the skin and cardiovascular disease
- Common Dermatologic Disorders in Down Syndrome: Systematic Review
- Psychotropic Medications and the Skin
- Skin problems in the long‐distance runner 2500 years after the Battle of Marathon
- The Cutaneous Side Effects of Selective BRAF Inhibitors and Anti-CTLA4 Agents: the Growing Role of the Dermatologist in the Management of Patients with Metastatic Melanoma
- Silicon in hair loss: a preliminary SEM microanalysis study
- The eosinophilia-myalgia syndrome
- Dermatology and Pregnancy
- Case Report: Bimekizumab for dissecting cellulitis of the scalp
- Cutaneous adverse reactions associated with enfortumab vedotin: a pharmacovigilance study based on the FDA adverse event reporting system